<VariationArchive VariationID="30353" VariationName="NM_004813.4(PEX16):c.952+118_*82del" VariationType="Deletion" Accession="VCV000030353" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39309" VariationID="30353">
      <GeneList>
        <Gene Symbol="PEX16" FullName="peroxisomal biogenesis factor 16" GeneID="9409" HGNC_ID="HGNC:8857" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="45909663" stop="45918822" display_start="45909663" display_stop="45918822" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="45931219" stop="45939673" display_start="45931219" display_stop="45939673" Strand="-" />
          </Location>
          <OMIM>603360</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004813.4(PEX16):c.952+118_*82del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="45910172" stop="45910780" display_start="45910172" display_stop="45910780" variantLength="609" positionVCF="45910171" referenceAlleleVCF="TGGGACGCTGCCGGAGTCAGTTTTATTAGGGAAGAGGGGCTCCCTGCCCCACCCCTCCCCACACCCTCCTTCCGGGAGGTCTGTCAGCCCCAACTGTAGAAGTAGATTTTCTGCCAGGTGGGCAAGTAATCCATGAGCGGCCCTGCAGTGGGAGAGGGACACATCAGGGCAGGCCAGACCCCAATCTGCACTGTGGCGCCACATACAGCACCTCACCCCTGCGGCCCAGGAGCCAGCCCAGCTGGCTGTCTTGCCCTGCCCCCAGGAGGCAGCACTGCAGGGGACTCTGGCACCATTTACAAAGACCCTCAGGCCCAGAGAAGCTCAGCCAGGGTAGACACTGAGGGGCCTGAGTCAGGTCCAGTCACCCAACCCAAGCCCAGTGGGCCTCTGCTGAGGGAGGATCTCAGCAGCCCGGTGGACCCCTTCTCTGCCATTGAATCCCCCCAAGATGAGATGGTCCCGTATCGCTCCAGGATACTGTGACCAGAAAAAAGCTGGCAGCTGATGTGGTCCCCCCACCAGTGGACACCCTCCTTCCAGCCATCCCTGGCTCCTCAGGCCACCCTGGCCTATGCCCAGGGGCAGTCCCACCCAATCCTGACTTCCC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="45931723" stop="45932331" display_start="45931723" display_stop="45932331" variantLength="609" positionVCF="45931722" referenceAlleleVCF="TGGGACGCTGCCGGAGTCAGTTTTATTAGGGAAGAGGGGCTCCCTGCCCCACCCCTCCCCACACCCTCCTTCCGGGAGGTCTGTCAGCCCCAACTGTAGAAGTAGATTTTCTGCCAGGTGGGCAAGTAATCCATGAGCGGCCCTGCAGTGGGAGAGGGACACATCAGGGCAGGCCAGACCCCAATCTGCACTGTGGCGCCACATACAGCACCTCACCCCTGCGGCCCAGGAGCCAGCCCAGCTGGCTGTCTTGCCCTGCCCCCAGGAGGCAGCACTGCAGGGGACTCTGGCACCATTTACAAAGACCCTCAGGCCCAGAGAAGCTCAGCCAGGGTAGACACTGAGGGGCCTGAGTCAGGTCCAGTCACCCAACCCAAGCCCAGTGGGCCTCTGCTGAGGGAGGATCTCAGCAGCCCGGTGGACCCCTTCTCTGCCATTGAATCCCCCCAAGATGAGATGGTCCCGTATCGCTCCAGGATACTGTGACCAGAAAAAAGCTGGCAGCTGATGTGGTCCCCCCACCAGTGGACACCCTCCTTCCAGCCATCCCTGGCTCCTCAGGCCACCCTGGCCTATGCCCAGGGGCAGTCCCACCCAATCCTGACTTCCC" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>DEL, EX11</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.45910173_45910781del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.45910173_45910781del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.45931724_45932332del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.45931724_45932332del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008460.1" sequenceAccession="NG_008460" sequenceVersion="1" change="g.12344_12952del">
            <Expression>NG_008460.1:g.12344_12952del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008460.2" sequenceAccession="NG_008460" sequenceVersion="2" change="g.13042_13650del">
            <Expression>NG_008460.2:g.13042_13650del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_057174.3" sequenceAccession="NM_057174" sequenceVersion="3" change="c.952+118_958del">
            <Expression>NM_057174.3:c.952+118_958del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004813.4" sequenceAccession="NM_004813" sequenceVersion="4" change="c.952+118_*82del" MANESelect="true">
            <Expression>NM_004813.4:c.952+118_*82del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008460.2" sequenceAccession="NG_008460" sequenceVersion="2" change="g.13041_13649del">
            <Expression>NG_008460.2:g.13041_13649del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603360.0005" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for OMIM allelic variant 603360.0005 from this description in the paper by Ebberink et al., 2010 (PubMed 20647552): "intragenic deletion in transcription variant 1 comprising the last 468 base pairs of intron 10, the entire exon 11a and the first 80 base pairs of the 39 flanking region of exon 11a and in transcription variant 2 comprising the last 603 base pairs of intron 10, and the first 4 base pairs of exon 11b".</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004813.4(PEX16):c.952+118_*82del AND Peroxisome biogenesis disorder 8B" Accession="RCV000023297" Version="2">
        <ClassifiedConditionList TraitSetID="8960">
          <ClassifiedCondition DB="MedGen" ID="C3553960">Peroxisome biogenesis disorder 8B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2010-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20647552</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8960" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17439" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 8B</ElementValue>
                <XRef ID="MONDO:0013943" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD8B</ElementValue>
                <XRef Type="MIM" ID="614877" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15870" />
                <XRef ID="15870" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012).
For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539.
Individuals with mutations in the PEX16 gene have cells of complementation group 9 (CG9, equivalent to CGD). For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614877" DB="OMIM" />
              </AttributeSet>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="C3553960" DB="MedGen" />
              <XRef ID="MONDO:0013943" DB="MONDO" />
              <XRef Type="MIM" ID="614877" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49844" SubmissionDate="2012-10-25" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603360.0005_PEROXISOME BIOGENESIS DISORDER 8B" title="PEX16, DEL, EX11_PEROXISOME BIOGENESIS DISORDER 8B" />
        <ClinVarAccession Accession="SCV000044588" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an Indian girl, born of consanguineous parents, with a relatively mild type of peroxisomal biogenesis disorder (PBD8B; 614877), Ebberink et al. (2010) identified a homozygous large intragenic deletion of intron 10 and exon 11 of the PEX16 gene. In transcript variant 1, the deletion affected the last 468 base pairs of intron 10, the entire exon 11a, and the first 80 base pairs of the 3-prime flanking region of exon 11a. In transcript variant 2, the deletion affected the last 603 base pairs of intron 10, and the first 4 base pairs of exon 11b. The deletion resulted in 3 alternative splice products. She showed normal development for the first year of life, but then stopped acquiring new skills, and lost her ability to walk independently at age 24 months due to spasticity and mild ataxia. Her speech and other cognitive functions also deteriorated slowly over time. At the age of 5 years, she had nystagmus, cataracts, hyperreflexia, clonus, and extensor plantar responses. Brain imaging showed diffuse white matter abnormalities and focal atrophy of the cerebellum and corpus callosum. Peripheral nerve velocity studies of the lower limbs suggested demyelination. Studies of skin fibroblasts showed that the peroxisomes were markedly enlarged in size and reduced in number compared to controls. However, biochemical studies showed only mild abnormalities, such as increased VLCFA, but most other peroxisomal functions appeared normal.</Attribute>
              <Citation>
                <ID Source="PubMed">20647552</ID>
              </Citation>
              <XRef DB="OMIM" ID="614877" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX16" />
          </GeneList>
          <Name>PEX16, DEL, EX11</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">DEL, EX11</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603360.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOME BIOGENESIS DISORDER 8B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49844" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOME BIOGENESIS DISORDER 8B" MappingRef="Preferred">
        <MedGen CUI="C3553960" Name="Peroxisome biogenesis disorder 8B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

